Invention Grant
- Patent Title: Triazolopyridine compounds as PIM kinase inhibitors
- Patent Title (中): 三唑并吡啶化合物作为PIM激酶抑制剂
-
Application No.: US14054459Application Date: 2013-10-15
-
Publication No.: US08895550B2Publication Date: 2014-11-25
- Inventor: Shelley Allen , Robert Kirk DeLisle , Julie Marie Hicks , Erik James Hicken , Joseph P. Lyssikatos , Fredrik P. Marmsater , Mark C. Munson , John E. Robinson , Qian Zhao
- Applicant: Array BioPharma Inc.
- Applicant Address: US CO Boulder
- Assignee: Array BioPharma Inc.
- Current Assignee: Array BioPharma Inc.
- Current Assignee Address: US CO Boulder
- Agency: Viksnins Harris & Padys
- Agent Sarah S. Mastous
- Main IPC: A61K31/437
- IPC: A61K31/437 ; A61K31/4353 ; C07D471/04
Abstract:
Provided herein are methods of treating diseases mediated by PIM-1 and/or PIM-2 and/or PIM-3 kinases by administering to a mammal in need thereof a therapeutically effective amount of a compound of Formula I: in which B, R1, R1a, R2, R3, R4, R5, R6, R7, R10 and R11 have the meanings given in the specification.
Public/Granted literature
- US20140045835A1 TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS Public/Granted day:2014-02-13
Information query
IPC分类:
